Genome editing using the endogenous type I CRISPR-Cas system in <i>Lactobacillus crispatus</i>.

Hidalgo-Cantabrana, Claudio; Goh, Yong Jun; Pan, Meichen; Sanozky-Dawes, Rosemary; Barrangou, Rodolphe · Proc Natl Acad Sci U S A · 2019

basic_science · Level V

Where this comes from

Abstract

CRISPR-Cas systems are now widely used for genome editing and transcriptional regulation in diverse organisms. The compact and portable nature of class 2 single effector nucleases, such as Cas9 or Cas12, has facilitated directed genome modifications in plants, animals, and microbes. However, most CRISPR-Cas systems belong to the more prevalent class 1 category, which hinges on multiprotein effector complexes. In the present study, we detail how the native type I-E CRISPR-Cas system, with a 5'-AAA-3' protospacer adjacent motif (PAM) and a 61-nucleotide guide CRISPR RNA (crRNA) can be repurposed for efficient chromosomal targeting and genome editing in <i>Lactobacillus crispatus</i>, an important commensal and beneficial microbe in the vaginal and intestinal tracts. Specifically, we generated diverse mutations encompassing a 643-base pair (bp) deletion (100% efficiency), a stop codon insertion (36%), and a single nucleotide substitution (19%) in the exopolysaccharide priming-glycosyl transferase (<i>p-gtf</i>). Additional genetic targets included a 308-bp deletion (20%) in the prophage DNA packaging <i>Nu1</i> and a 730-bp insertion of the green fluorescent protein gene downstream of enolase (23%). This approach enables flexible alteration of the formerly genetically recalcitrant species <i>L. crispatus</i>, with potential for probiotic enhancement, biotherapeutic engineering, and mucosal vaccine delivery. These results also provide a framework for repurposing endogenous CRISPR-Cas systems for flexible genome targeting and editing, while expanding the toolbox to include one of the most abundant and diverse systems found in nature.

Medical subject headings